Dacryocystitis: Difference between revisions
(Added adjunct tx) |
No edit summary |
||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Acute or chronic inflammation and bacterial infection of the lacrimal sac | *Acute or chronic inflammation and bacterial infection of the lacrimal sac | ||
**Most common pathogens: | **Most common pathogens: ''S. pneumoniae'', ''S. aureus'', ''S. epidermidis'', ''H. influenzae'' | ||
*Most common in children | *Most common in children | ||
*Often after viral URI | *Often occurs after viral URI | ||
*Complications: [[Periorbital | *Complications: [[Periorbital cellulitis]], [[Orbital cellulitis]], [[Meningitis]] | ||
==Clinical Features== | ==Clinical Features== | ||
*Mucopurulent material expressed from nasolacrimal sac | *Mucopurulent material expressed from nasolacrimal sac | ||
*Erythema and edema between medial canthus and nasal bridge | *Erythema and edema between medial canthus and nasal bridge | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
| Line 18: | Line 14: | ||
{{Neonatal eye problems DDX}} | {{Neonatal eye problems DDX}} | ||
==Evaluation== | |||
*Generally a clinical diagnosis | |||
*Consider culture of any purulent drainage | |||
==Management== | ==Management== | ||
* | *[[Clindamycin]] PO for 7-10 days | ||
*Decongestants | *Decongestants | ||
*Warm compress | *Warm compress | ||
*If toxic-appearing: IV [[Cephalosporin]] ([[Cefuroxime]] 50mg/kg IV Q8h '''OR''' [[Cefazolin]] 33mg/kg IV Q6H) '''OR''' [[Clindamycin]] (10mg/kg IV Q8H) | |||
**If [[MRSA]] suspected, add [[Vancomycin]] | |||
*Chronic dacryocystitis: topical ([[fluoroquinolone]] or [[erythromycin]]) | |||
==Disposition== | |||
*Generally may be discharged with ophthalmology follow-up | |||
==See Also== | |||
==External Links== | |||
==References== | ==References== | ||
<references/> | |||
Revision as of 05:36, 4 November 2017
Background
- Acute or chronic inflammation and bacterial infection of the lacrimal sac
- Most common pathogens: S. pneumoniae, S. aureus, S. epidermidis, H. influenzae
- Most common in children
- Often occurs after viral URI
- Complications: Periorbital cellulitis, Orbital cellulitis, Meningitis
Clinical Features
- Mucopurulent material expressed from nasolacrimal sac
- Erythema and edema between medial canthus and nasal bridge
Differential Diagnosis
Periorbital swelling
Proptosis
- Normal IOP
- Orbital cellulitis
- Orbital pseudotumor
- Orbital tumor
- Increased IOP
- Retrobulbar abscess
- Retrobulbar emphysema
- Retrobulbar hemorrhage
- Ocular compartment syndrome
- Orbital tumor
No proptosis
- Periorbital cellulitis/erysipelas
- Dacryocystitis (lacrimal duct)
- Dacryocele/Dacryocystocele
- Dacryostenosis
- Dacryoadenitis (lacrimal gland)
- Allergic reaction
- Nephrotic Syndrome (pediatrics)
Lid Complications
- Blepharitis (crusts)
- Chalazion (meibomian gland)
- Stye (hordeolum) (eyelash folicle)
Other
- Subperiosteal abscess
- Orbital abscess
- Cavernous sinus thrombosis
- Conjunctivitis
- Contact dermatitis
- Herpes zoster
- Herpes simplex
- Sarcoidosis
- Granulomatosis with polyangiitis
Neonatal eye problems
- Nasolacrimal duct obstruction
- Dacrocystitis
- Conjunctivitis
- Chemical
- Gonococcal
- Chlamydia
- Herpetic
- Streptococcus/S. Aureus
- Early onset glaucoma
- Uveitis
- Ocular foreign body
- Corneal abrasion
- Ocular trauma
- Ingrown eyelash
Evaluation
- Generally a clinical diagnosis
- Consider culture of any purulent drainage
Management
- Clindamycin PO for 7-10 days
- Decongestants
- Warm compress
- If toxic-appearing: IV Cephalosporin (Cefuroxime 50mg/kg IV Q8h OR Cefazolin 33mg/kg IV Q6H) OR Clindamycin (10mg/kg IV Q8H)
- If MRSA suspected, add Vancomycin
- Chronic dacryocystitis: topical (fluoroquinolone or erythromycin)
Disposition
- Generally may be discharged with ophthalmology follow-up